Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 203.13M
March 31, 2026 230.93M
December 31, 2025 302.21M
September 30, 2025 368.91M
June 30, 2025 455.79M
March 31, 2025 518.03M
December 31, 2024 589.45M
September 30, 2024 658.54M
June 30, 2024 706.96M
March 31, 2024 759.54M
December 31, 2023 240.34M
September 30, 2023 256.85M
June 30, 2023 307.83M
March 31, 2023 343.36M
December 31, 2022 382.76M
Date Value
September 30, 2022 163.37M
June 30, 2022 216.76M
March 31, 2022 268.89M
December 31, 2021 310.68M
September 30, 2021 173.27M
June 30, 2021 216.56M
March 31, 2021 239.80M
December 31, 2020 154.08M
September 30, 2020 178.48M
June 30, 2020 212.83M
March 31, 2020 244.10M
December 31, 2019 211.43M
September 30, 2019 230.05M
June 30, 2019 266.88M
March 31, 2019 188.41M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Bicycle Therapeutics Plc 510.05M
Biodexa Pharmaceuticals Plc --
argenx SE --
NuCana Plc 25.89M
Mereo BioPharma Group Plc 30.12M